Form 8-K - Current report:
SEC Accession No. 0001437749-23-027662
Filing Date
2023-10-04
Accepted
2023-10-04 16:07:08
Documents
86
Period of Report
2023-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vtgn20231003_8k.htm   iXBRL 8-K 47569
2 EXHIBIT 1.1 ex_576126.htm EX-1.1 295516
3 EXHIBIT 4.1 ex_576134.htm EX-4.1 90796
4 EXHIBIT 4.2 ex_576135.htm EX-4.2 191362
5 EXHIBIT 4.3 ex_576136.htm EX-4.3 190987
6 EXHIBIT 5.1 ex_576182.htm EX-5.1 40462
7 EXHIBIT 99.1 ex_576137.htm EX-99.1 38029
8 EXHIBIT 99.2 ex_576138.htm EX-99.2 15742
13 a01.jpg GRAPHIC 53441
14 a02.jpg GRAPHIC 134077
15 a03.jpg GRAPHIC 67019
16 a04.jpg GRAPHIC 61062
17 a05.jpg GRAPHIC 44295
18 a06.jpg GRAPHIC 69293
19 a07.jpg GRAPHIC 42856
20 a08.jpg GRAPHIC 63189
21 a09.jpg GRAPHIC 64608
22 a10.jpg GRAPHIC 57065
23 a11.jpg GRAPHIC 55917
24 a12.jpg GRAPHIC 57521
25 a13.jpg GRAPHIC 80511
26 a14.jpg GRAPHIC 59165
27 a15.jpg GRAPHIC 52553
28 a16.jpg GRAPHIC 83281
29 a17.jpg GRAPHIC 84995
30 a18.jpg GRAPHIC 81537
31 a19.jpg GRAPHIC 42824
32 a20.jpg GRAPHIC 58234
33 a21.jpg GRAPHIC 58375
34 a22.jpg GRAPHIC 53150
35 a23.jpg GRAPHIC 56682
36 a24.jpg GRAPHIC 81512
37 a25.jpg GRAPHIC 84248
38 a26.jpg GRAPHIC 103075
39 a27.jpg GRAPHIC 108598
40 a28.jpg GRAPHIC 43297
41 a29.jpg GRAPHIC 61984
42 a30.jpg GRAPHIC 77098
43 a31.jpg GRAPHIC 79269
44 a32.jpg GRAPHIC 54485
45 a33.jpg GRAPHIC 59004
46 a34.jpg GRAPHIC 52731
47 a35.jpg GRAPHIC 80759
48 a36.jpg GRAPHIC 93685
49 a37.jpg GRAPHIC 88400
50 a38.jpg GRAPHIC 55495
51 a39.jpg GRAPHIC 66927
52 a40.jpg GRAPHIC 100693
53 a41.jpg GRAPHIC 52057
54 a42.jpg GRAPHIC 57157
55 a43.jpg GRAPHIC 55345
56 a44.jpg GRAPHIC 64909
57 a45.jpg GRAPHIC 81349
58 a46.jpg GRAPHIC 52521
59 a47.jpg GRAPHIC 70205
60 a48.jpg GRAPHIC 80601
61 a49.jpg GRAPHIC 50766
62 a50.jpg GRAPHIC 70294
63 a51.jpg GRAPHIC 65582
64 a52.jpg GRAPHIC 73482
65 a53.jpg GRAPHIC 48825
66 a54.jpg GRAPHIC 45252
67 a55.jpg GRAPHIC 66439
68 a56.jpg GRAPHIC 64723
69 a57.jpg GRAPHIC 67165
70 a58.jpg GRAPHIC 55137
71 a59.jpg GRAPHIC 91095
72 a60.jpg GRAPHIC 89722
73 a61.jpg GRAPHIC 81055
74 a62.jpg GRAPHIC 82075
75 ex_576138img001.jpg GRAPHIC 4233
76 wood01.jpg GRAPHIC 7469
77 wood02.jpg GRAPHIC 18444
78 woodburn02.jpg GRAPHIC 7999
  Complete submission text file 0001437749-23-027662.txt   7120219

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20231002.xsd EX-101.SCH 3409
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20231002_def.xml EX-101.DEF 11424
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20231002_lab.xml EX-101.LAB 15310
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20231002_pre.xml EX-101.PRE 11584
80 EXTRACTED XBRL INSTANCE DOCUMENT vtgn20231003_8k_htm.xml XML 2563
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 231307956
SIC: 2834 Pharmaceutical Preparations